glp 1 zepbound tirzepatide Weight Loss Injections • Fit 4 Life Weight Loss Medical Center Understand GLP-1/GIP Dual Agonist Tirzepatide

Many individuals who are overweight may be eligible for treatment with GLP-1 medications, no matter their age or ethnic background

Khan Y, Imershein S, Maryniuk M, Armian H, Turkistani SA, Bayoumi AH, Al-Harbi MY, Hsu WC (2020b) A program utilizing community pharmacists to improve diabetes education in the Kingdom of Saudi Arabia

Individualized Treatment : For patients with significant cardiovascular disease or heart failure, the decision to use Ozempic-like drugs must be individualized, weighing the benefits of glycemic control and weight loss against the potential risks, including muscle loss and any unknown cardiovascular effects

Mol Immunol (2009) 46(16):343844

Why the Dual Targeting Matters While GLP-1 receptor agonists like semaglutide are already successful in treating type 2 diabetes, combining it with GIP signaling unlocks greater benefits